Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer
Objective. Evidence demonstrates that the immune microenvironment is extensively associated with chemotherapy response of ovarian cancer (OV). Herein, this study is aimed at establishing a cisplatin response prediction model for OV on the basis of immune genes. Methods. The expression profiles of ci...
Saved in:
Main Authors: | Ying Guo, Na Yang, Gang Li, Xiurong Yin, Lixia Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/4379216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9
by: Xinxin Kou, et al.
Published: (2021-01-01) -
Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01) -
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
by: Lei Dou, et al.
Published: (2025-02-01) -
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
by: Lydia C. Powell, et al.
Published: (2025-02-01) -
Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
by: Taha Umair Wani, et al.
Published: (2025-01-01)